Venous Thromboembolic Disease

  • Reena Julka
  • Christopher J. Wong
Chapter

Abstract

The risk of new or recurrent Venous Thromboembolism versus the risk of perioperative bleeding while on anticoagulation should always be discussed with the surgeon.

Keywords

Obesity Catheter Europe Aspirin Heparin 

References

  1. 1.
    Lip G. Management of anticoagulation before and after elective surgery. UptoDate. Article revision date 9/2011. Accessed Jan 2012.Google Scholar
  2. 2.
    Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;336:1506–11.PubMedCrossRefGoogle Scholar
  3. 3.
    University of Washington Department of Pharmacy Anticoagulation Services. www.uwmcacc.org. Last update 5/10. Accessed Dec 2011.
  4. 4.
    Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy. Chest. 2012;141(2 Suppl):e326S–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2008;133:454–545.CrossRefGoogle Scholar
  6. 6.
  7. 7.
    Fedullo P, et al. Inferior vena cava filters. UptoDate. Article revision date 10/2009.Google Scholar
  8. 8.
    Imberti D, Biachi M, Farina A, et al. Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. J Thromb Haemost. 2005;3:1370–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Mismetti P, Rivron-Guillot K, Quenet S, et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest. 2007;131:223–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Falck-Ytter Y, Francis CW, Johanson NA Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S–325.PubMedCrossRefGoogle Scholar
  11. 11.
    Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e227S–77.PubMedCrossRefGoogle Scholar
  12. 12.
    American Academy of Orthopaedic Surgeons—Medical Specialty Society. 2007 May. American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. http://www.ngc.gov/content.aspx?, id=10850. Accessed Dec 2011.
  13. 13.
    Galanis T, Thomson L, Palladino M, et al. New oral anticoagulants. J Thromb Thrombolysis. 2011;31(3):310–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Erkens P, Prins M. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2010; CD001100.Google Scholar
  15. 15.
    Jaff MR, McMurtry S, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123:1788–830.PubMedCrossRefGoogle Scholar
  16. 16.
    Kearon C, Aki EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S–94.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Reena Julka
    • 1
  • Christopher J. Wong
    • 2
  1. 1.Department of Medicine, Division of General Internal MedicineUniversity of Washington, Medical CenterSeattleUSA
  2. 2.Department of Medicine, Division of General Internal MedicineUniversity of Washington Medical CenterSeattleUSA

Personalised recommendations